RHJA
CLB icon

Rice Hall James & Associates’s Core Laboratories CLB Stock Holding History

Rice Hall James & Associates’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Buy
101,648
+2,552
+3% +$36.4K 0.06% 193
2026
Q1 		$1.66M Sell
99,096
-197
-0.2% -$3.52K 0.09% 178
2025
Q4 		$1.59M Sell
99,293
-22,158
-18% -$330K 0.09% 177
2025
Q3 		$1.5M Sell
121,451
-57,334
-32% -$672K 0.08% 182
2025
Q2 		$2.06M Sell
178,785
-15,013
-8% -$178K 0.11% 156
2025
Q1 		$2.91M Buy
193,798
+80,595
+71% +$1.35M 0.17% 128
2024
Q4 		$1.96M Buy
+113,203
New +$2.18M 0.11% 180
2019
Q2 		– Sell
-17,520
Closed -$1.21M – 278
2019
Q1 		$1.21M Sell
17,520
-215
-1% -$14.4K 0.04% 241
2018
Q4 		$1.06M Sell
17,735
-1,024
-5% -$88.4K 0.04% 244
2018
Q3 		$2.17M Sell
18,759
-111
-0.6% -$12.5K 0.08% 163
2018
Q2 		$2.38M Sell
18,870
-2,340
-11% -$285K 0.09% 169
2018
Q1 		$2.29M Sell
21,210
-94
-0.4% -$10.4K 0.09% 156
2017
Q4 		$2.33M Sell
21,304
-2,436
-10% -$243K 0.09% 178
2017
Q3 		$2.34M Hold
23,740
– – 0.1% 173
2017
Q2 		$2.4M Buy
23,740
+7
+0% +$755 0.1% 160
2017
Q1 		$2.74M Sell
23,733
-456
-2% -$53K 0.13% 133
2016
Q4 		$2.9M Sell
24,189
-132
-0.5% -$14.6K 0.15% 122
2016
Q3 		$2.73M Sell
24,321
-327
-1% -$37.7K 0.14% 134
2016
Q2 		$3.05M Sell
24,648
-595
-2% -$71.8K 0.18% 106
2016
Q1 		$2.84M Sell
25,243
-453
-2% -$47.1K 0.16% 117
2015
Q4 		$2.79M Sell
25,696
-8,329
-24% -$953K 0.16% 122
2015
Q3 		$3.4M Buy
34,025
+1,273
+4% +$138K 0.22% 101
2015
Q2 		$3.73M Sell
32,752
-1,421
-4% -$172K 0.22% 104
2015
Q1 		$3.57M Buy
+34,173
New +$3.64M 0.21% 119

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Rice Hall James & Associates's CLB Position: Q2 2026 in Review

Rice Hall James & Associates increased its Core Laboratories (CLB) stake by 2.6% in Q2 2026, buying an estimated $36.4K and bringing the position to 101,648 shares worth $1.18M. The position accounts for 0.06% of the portfolio, ranked #193.

Rice Hall James & Associates first reported a position in CLB in Q1 2015 and has held it in 24 quarters since. The position peaked at $3.73M in Q2 2015. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Rice Hall James & Associates held 101,648 shares of Core Laboratories worth $1.18M as of Q2 2026.
  • Rice Hall James & Associates bought 2,552 Core Laboratories shares in Q2 2026, an estimated $36.4K.
  • Core Laboratories made up 0.06% of Rice Hall James & Associates's portfolio in Q2 2026, its #193 holding.
  • Rice Hall James & Associates first reported a position in Core Laboratories in Q1 2015 and has held it in 24 quarters since.
  • Rice Hall James & Associates's Core Laboratories position peaked at $3.73M in Q2 2015.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Rice Hall James & Associates's 13F filing for Q2 2026, filed 7 Aug 2026.